Full Year Inflows Send Vertex Pharma Shares Soaring

Vertex Shares Surge with Inflows

Institutional volumes reveal plenty. Over the past year, VRTX’s stock has jumped as volumes increased. That’s indicative of healthy institutional support.

Each green bar signals unusually large volumes in VRTX shares, pushing the stock higher:

Plenty of healthcare names are under accumulation right now. But there’s a powerful fundamental backdrop going on with Vertex.

Vertex Pharma Fundamental Analysis

Institutional support coupled with a healthy fundamental backdrop makes this company interesting. As you can see, VRTX has had positive sales & earnings growth in recent years:

• 3-year sales growth rate (+29.3%)
• 3-year EPS growth rate (+52.5%)

Source: FactSet

Now it makes sense why the stock has been powering higher. VRTX is an earnings powerhouse.

Marrying great fundamentals with our proprietary software has found some big winning stocks over the long-term.

Vertex has been a top-rated stock at MAPsignals. That means the stock has had unusual buy pressure and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis.

It’s made the rare Top 20 report many times. The blue bars below shows when VRTX was a top pick:

Tracking unusual volumes reveals the power of money flows.

This is a trait that most outlier stocks exhibit.

Vertex Pharma Price Prediction

The VRTX rally began months ago. Big Money buying in the shares is signaling to take notice. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a diversified portfolio.

Disclosure: the author holds no position in VRTX at the time of publication.

If you are a Registered Investment Advisor (RIA) or are a serious investor, take your investing to the next level, learn more about the MAPsignals process here.